Michael Crews
Analyst · BMO Capital Markets. Please go ahead
Well, thank you, Belgacem, and good morning. We are pleased to report solid operational and financial performance for the second quarter that led to higher adjusted EBITDA and margins and strong cash flow generation, coupled with proceeds from an asset sale, allowed us to repay the $100 million of term loan in August. So beginning with Slide 4 with a review of our consolidated related results. Sales of $432 million were in line with the prior year period. On a constant currency basis, sales increased 1.4%, driven by price increases across the portfolio, which helped to offset lower volumes. Adjusted EBITDA of $132 million increased 2.8% or 4.6% on a constant currency basis. Improved operational performance in both Refining Services and Catalyst drove most of the upside, offsetting the impact of weaker demand in Performance Chemicals. Adjusted EBITDA margin of 28% increased approximately 150 basis points. Shifting to a discussion by business segment and for Refining Services on Slide 5, sales rose 5% to $117 million. We benefited from favorable mix and higher average pricing, with the rolloff of a legacy contract for virgin asset that was at below market levels. Volumes were lower, driven mainly by unplanned customer outages that extended into the second quarter from the first quarter. Adjusted EBITDA was up 3.6% on higher sales to approximately $43 million and adjusted EBITDA margin remains strong at 36.5%. Turn next on Slide 6 for a review of Catalyst. Silica catalyst sales of nearly $21 million rose 21%, driven by continued strong demand for polyolefin catalyst, coupled with an order that accelerated into the second quarter from the second half of 2019. Zeolyst Joint Venture sales of approximately $39 million were down 21%. This was attributable to order timing for hydrocracking and specialty catalysts, as expected, and shipment delays due to flooding in the Midwest. Adjusted EBITDA of $29.6 million was up 25%, resulting in a margin of 49%. The outperformance was driven by favorable product mix and higher absorption of fixed cost as we built inventory to meet shipments planned for the third quarter. Some of this benefit will reverse as we sell through inventory in the second half of 2019, and along with a higher proportion of hydrocracking catalyst sales, we expect margins in this segment for 2019 to approximate prior year levels. Now for Performance Materials on Slide 7. Sales of $119 million were down 6% or 3.5% on a constant currency basis. Continued higher pricing for Highway Safety products, coupled with a favorable mix, was more than offset by lower volumes. This volume decline was largely attributable to poor North America weather conditions that impacted our Highway Safety product sales, lower ThermoDrop volumes as we selectively focused on customers who recognized the premium value of this product and a slowdown in Europe for weaker industrial and automotive end uses. Adjusted EBITDA of $29.2 million increased 2.1% or 3.9% on a constant currency basis and margins improved by 200 basis points to 24.6%. This was the result of capturing price increases, favorable product mix and lower freight costs with better utilization. Turning to Slide 8 for Performance Chemicals. Sales of nearly $178 million were down 3.3% but were flat on a constant currency basis as higher prices mitigated slowing demand in Europe and Mexico and for consumer cleaning products, globally. Adjusted EBITDA was $41.2 million, down 8% or 4.8% on a constant currency basis, resulting in a lower margin. While our price increases covered higher raw material cost, lower adjusted EBITDA margin were largely due to weaker demand, higher maintenance costs and an unfavorable currency impact of $1.5 million. Moving to Slide 9 for our 2019 guidance. With our solid first half performance and expectations for continued portfolio stability despite some pockets of softness in Europe, we are well positioned to meet our key financial objectives for 2019, specifically adjusted EBITDA and adjusted free cash flow. With respect to our sales outlook, through the first half of the year, we've experienced headwinds from the pass-through of lower sulfur costs and lower volumes and expect further deterioration in sulfur pricing. We are, therefore, adjusting our sales outlook to be in the range of $1.58 billion to $1.6 billion from $1.64 billion to $1.67 billion to reflect the estimated full year impact of these factors. However, based on higher pricing, favorable mix and effective cost management, we are maintaining our 2019 adjusted EBITDA guidance in the range of $470 million to $485 million, with adjusted EBITDA margins similar to 2018 levels. For depreciation and amortization, we now expect to be in the range of $185 million to $195 million, down from $190 million to $200 million, given some capital spending has shifted to the second half of the year. As a result of the lower depreciation and amortization, we are raising the lower end of our adjusted diluted EPS guidance to be in the range of $0.77 to $0.93 per share. As a reminder, amortization expense for acquisition-related intangibles is not added back as part of our definition of adjusted diluted EPS. This represents approximately $0.28 per share for 2019. Moving to the outlook at the business segment level. For Refining Services, we expect sales to be down slightly by low single digits, reflecting lower sulfur pass-through while adjusted EBITDA is expected to increase in the low single-digit range, driven by higher average pricing. For Catalysts, we expect silica catalysts and the Zeolyst Joint Venture sales and segment adjusted EBITDA growth in the double-digit range from expected robust sales demand for polyolefin, MMA and hydrocracking catalyst. Performance Materials sales are expected to be down slightly year-over-year on lower volumes but expect high-single digit adjusted EBITDA growth on pricing drop-through, favorable mix and improving logistical cost. Finally, for Performance Chemicals, we expect sales to be flat and adjusted EBITDA down low single digits due to anticipated weaker demand in Europe, unfavorable foreign exchange and that the benefits of higher prices are only offsetting higher raw material costs. For the third quarter 2019, we anticipate GAAP sales largely in line with Q2 levels on the pass-through pricing of lower sulfur costs. Zeolyst Joint Venture sales are expected to be strong on higher hydrocracking catalyst sales. Adjusted EBITDA is expected to be in line with the second quarter but up low double digits versus the prior year third quarter, given the timing of orders for hydrocracking and specialty catalyst sales in the Zeolyst Joint Venture and improved results from Performance Materials as higher demand and lower costs are expected to drive growth over prior year. So to reiterate our key financial objectives, we are on track to generate adjusted free cash flow in the range of $125 million to $145 million, which excludes the sale proceeds from the sulfate salts product line. We continue to dedicate free cash flow to debt repayment as evidenced this week with our recent reduction of our term loan by $100 million. It is our expectation that by year-end, our net debt to adjusted EBITDA leverage ratio will fall to approximately four times. With that overview of our second quarter results, I will now turn the call back over to Belgacem.